Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer

This cohort study uses published clinical trial data to assess long-term survival of patients with metastatic urothelial carcinoma who are treated with immune checkpoint inhibitors.

Detalles Bibliográficos
Autores principales: Zhu, Alec, Garcia, Jorge Alberto, Faltas, Bishoy, Grivas, Petros, Barata, Pedro, Shoag, Jonathan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098944/
https://www.ncbi.nlm.nih.gov/pubmed/37043205
http://dx.doi.org/10.1001/jamanetworkopen.2023.7444
_version_ 1785024936792817664
author Zhu, Alec
Garcia, Jorge Alberto
Faltas, Bishoy
Grivas, Petros
Barata, Pedro
Shoag, Jonathan E.
author_facet Zhu, Alec
Garcia, Jorge Alberto
Faltas, Bishoy
Grivas, Petros
Barata, Pedro
Shoag, Jonathan E.
author_sort Zhu, Alec
collection PubMed
description This cohort study uses published clinical trial data to assess long-term survival of patients with metastatic urothelial carcinoma who are treated with immune checkpoint inhibitors.
format Online
Article
Text
id pubmed-10098944
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-100989442023-04-14 Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer Zhu, Alec Garcia, Jorge Alberto Faltas, Bishoy Grivas, Petros Barata, Pedro Shoag, Jonathan E. JAMA Netw Open Research Letter This cohort study uses published clinical trial data to assess long-term survival of patients with metastatic urothelial carcinoma who are treated with immune checkpoint inhibitors. American Medical Association 2023-04-12 /pmc/articles/PMC10098944/ /pubmed/37043205 http://dx.doi.org/10.1001/jamanetworkopen.2023.7444 Text en Copyright 2023 Zhu A et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Zhu, Alec
Garcia, Jorge Alberto
Faltas, Bishoy
Grivas, Petros
Barata, Pedro
Shoag, Jonathan E.
Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer
title Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer
title_full Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer
title_fullStr Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer
title_full_unstemmed Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer
title_short Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer
title_sort immune checkpoint inhibitors and long-term survival of patients with metastatic urothelial cancer
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098944/
https://www.ncbi.nlm.nih.gov/pubmed/37043205
http://dx.doi.org/10.1001/jamanetworkopen.2023.7444
work_keys_str_mv AT zhualec immunecheckpointinhibitorsandlongtermsurvivalofpatientswithmetastaticurothelialcancer
AT garciajorgealberto immunecheckpointinhibitorsandlongtermsurvivalofpatientswithmetastaticurothelialcancer
AT faltasbishoy immunecheckpointinhibitorsandlongtermsurvivalofpatientswithmetastaticurothelialcancer
AT grivaspetros immunecheckpointinhibitorsandlongtermsurvivalofpatientswithmetastaticurothelialcancer
AT baratapedro immunecheckpointinhibitorsandlongtermsurvivalofpatientswithmetastaticurothelialcancer
AT shoagjonathane immunecheckpointinhibitorsandlongtermsurvivalofpatientswithmetastaticurothelialcancer

Ejemplares similares